title: [Criteria of the eligibility of patients for treatment with intravenous normal human immunoglobulin].
authors: Service d'hématologie adulte, CHU Brabois, allée du Morvan, 54511 Vandoeuvre, France. p.feugier@chu-nancy.fr
authors: P
authors: P
authors: Feugier
authors: C
authors: C
authors: Tomowiak
authors: N
authors: N
authors: Daguindau
authors: A
authors: A
authors: Perrot
mesh_terms: D000367:Age Factors; D000368:Aged; D015331:Cohort Studies; D003627:Data Interpretation, Statistical; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007239:Infections / Q000150:complications; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008137:Longitudinal Studies; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D018579:Patient Selection; D012737:Sex Factors; D013997:Time Factors
chemical_list: D016756:Immunoglobulins, Intravenous